Technology News and Research

RSS

FDA approves 'Cornell Dots' for first clinical trial in humans to diagnose cancer

"Cornell Dots" - brightly glowing nanoparticles - may soon be used to light up cancer cells to aid in diagnosing and treating cancer. The U.S. Food and Drug Administration has approved the first clinical trial in humans of the new technology.

1 Feb 2011

Duke, LifePoint enter joint venture to improve healthcare delivery for North Carolina community hospitals

Duke University Health System, Inc. and LifePoint Hospitals® have formed DLP Healthcare, LLC (Duke/LifePoint), a joint venture designed to strengthen and improve healthcare delivery throughout North Carolina and the surrounding regions by creating flexible affiliation options for community hospitals.

1 Feb 2011

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

BioMimetic Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled an Orthopedic and Rehabilitation Devices Panel meeting on May 12, 2011 to review the Company's Premarket Approval (PMA) application for Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S.

1 Feb 2011

CINJ Foundation, Panera Bread enter joint venture to fight against cancer

Panera Bread has expanded its contributions to the fight against cancer by selecting the Cancer Institute of New Jersey Foundation as its Community Breadbox Partner for 2011.

1 Feb 2011

Favorable clinical results from Endologix's Nellix technology against EVAR

Endologix, developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm.

1 Feb 2011

DNA Direct implements four new health plan clients for molecular diagnostic and genetic tests

DNA Direct, a wholly owned subsidiary of Medco Health Solutions, Inc. and a provider of guidance and decision support for genomic medicine, today announced four new health plan clients that are implementing DNA Direct's Policy & Benefit Support Program for molecular diagnostic and genetic tests.

1 Feb 2011

HighRes Biosolutions to build High-Throughput Laboratory Network for LANL-UCLA

A compact, self-contained, automated system for surveillance and screening of potential pandemic strains of influenza and other deadly infectious diseases is a step closer to reality, thanks to an agreement between Los Alamos National Laboratory, the University of California Los Angeles School of Public Health, and HighRes Biosolutions of Boston, Massachussets.

1 Feb 2011

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that it has received approval from Health Canada for the Acculis Accu2i percutaneous microwave tissue ablation system for the coagulation of soft tissue during surgical procedures.

1 Feb 2011

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

ImaginAb, and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia pastoris expression system.

1 Feb 2011

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

Covidien, a leading global provider of healthcare products, today announced that its new Endo GIA curved tip and black reloads with Tri-Staple technology are available in limited release with a full U.S. roll out expected by mid-year.

1 Feb 2011

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

Abbott today announced it has received regulatory clearance in the United States and approval in Japan for its TREK and MINI-TREK Coronary Dilatation Catheters for the treatment of coronary artery disease. The TREK system is used in angioplasty procedures and is designed to enable interventional cardiologists to open patients' narrowed coronary arteries. The TREK system received CE Mark and was launched in Europe in May 2010.

1 Feb 2011

Cappella initiates multi-center Italian Sideguard open label clinical study

Cappella Medical Devices announces initiation of the multi-center Italian Sideguard® open label clinical study. The Principal Investigator (PI) of the study, Dr. Giuseppe Massimo Sangiorgi at the Policlinico di Modena - University of Modena and Reggio Emilia, in Modena, Italy stated, "The side branch ostium anatomy requires a unique technology solution to effectively manage and optimize treatment.

1 Feb 2011

FDA approves ultrasmall silica inorganic nanoparticle INDA for targeted molecular imaging of cancer

Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application from the US Food and Drug Administration for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

31 Jan 2011

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

Florida-based biopharmaceutical company Oragenics, today announced its intention to commence a second phase 1 clinical trial of SMaRT Replacement Therapy.

31 Jan 2011

Researchers to develop computer-assisted diagnosis tools for pathologists

Researchers are leveraging Ohio Supercomputer Center resources to develop computer-assisted diagnosis tools that will provide pathologists grading Follicular Lymphoma samples with quicker, more consistently accurate diagnoses.

31 Jan 2011

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the initiation of two studies to further evaluate the efficacy and safety of VB-111 in advanced cancers.

31 Jan 2011

Baxter launches OLIMEL emulsion for parenteral nutrition

Baxter International today announced the launch of OLIMEL emulsion for infusion in Canada at the American Society of Parenteral and Enteral Nutrition's Clinical Nutrition Week.

From Baxter International Inc. 31 Jan 2011

Revolutions Medical: Major breakthrough in automatic retractable prefilled safety syringe technology

Revolutions Medical Corporation announces a major breakthrough in automatic retractable prefilled safety syringe technology. Building on the Company's proprietary vacuum based technology, important improvements in performance have been made that will set a new gold standard for safety in automatic prefilled syringes.

31 Jan 2011

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Encision, a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its third fiscal quarter ended December 31, 2010.

31 Jan 2011

CircusFit, Ringling Bros, HOPSports announce new partnership to encourage kids to stay active, healthy

Ringling Bros. CircusFit and HOPSports announce new partnership that will allow children around the world to get physically fit while having fun. CircusFit will be powered by the HOPSports Training System combining circus skills with state of the art technology to encourage youth to stay active and healthy.

31 Jan 2011

Technology News and Research

FDA approves 'Cornell Dots' for first clinical trial in humans to diagnose cancer

Duke, LifePoint enter joint venture to improve healthcare delivery for North Carolina community hospitals

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

CINJ Foundation, Panera Bread enter joint venture to fight against cancer

Favorable clinical results from Endologix's Nellix technology against EVAR

DNA Direct implements four new health plan clients for molecular diagnostic and genetic tests

HighRes Biosolutions to build High-Throughput Laboratory Network for LANL-UCLA

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

Cappella initiates multi-center Italian Sideguard open label clinical study

FDA approves ultrasmall silica inorganic nanoparticle INDA for targeted molecular imaging of cancer

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

Researchers to develop computer-assisted diagnosis tools for pathologists

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

Baxter launches OLIMEL emulsion for parenteral nutrition

Revolutions Medical: Major breakthrough in automatic retractable prefilled safety syringe technology

Encision reports gross profit margin increase in third quarter of fiscal year 2011

CircusFit, Ringling Bros, HOPSports announce new partnership to encourage kids to stay active, healthy

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News